The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
about
RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast developmentProfile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromesGlobal transcriptome analyses of human and murine terminal erythroid differentiation.Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised conditionFOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis.Splenectomy improves anaemia but does not reduce iron burden in patients with haemoglobin H Constant Spring disease.Preconditioning with hemin decreases Plasmodium chabaudi adami parasitemia and inhibits erythropoiesis in BALB/c mice.When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.Coordinate expression of heme and globin is essential for effective erythropoiesisReducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.Non-transfusion-dependent thalassemias.Iron refractory iron deficiency anemiaPhysiology and pathophysiology of iron in hemoglobin-associated diseases.Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.Complete recovery from paraparesis in spinal cord compression due to extramedullary haemopoiesis in beta-thalassaemia by emergency radiation therapy.Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.Management of non-transfusion-dependent thalassemia: a practical guide.Iron age: novel targets for iron overload.Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.A complicated disease: what can be done to manage thalassemia major more effectively?Increasing prevalence of thalassemia in America: Implications for primary care.Revisiting beta thalassemia intermedia: past, present, and future prospects.Morbidities in non-transfusion-dependent thalassemia.Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review.First Report of a Dominantly Inherited β-Thalassemia Caused by a Novel Elongated β-Globin Chain.Targeting a new regulator of erythropoiesis to alleviate anemia.Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.Myelofibrosis, JAK2 inhibitors and erythropoiesis.Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.What can we learn from ineffective erythropoiesis in thalassemia?Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study.Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major.Ineffective Erythropoiesis: Anemia and Iron Overload.Proton pump inhibitors use suppresses iron absorption in congenital dyserythropoietic anemia.
P2860
Q24301698-E2C52687-7404-4185-8E36-77918BE38E34Q26771519-4C84B4BE-1981-486A-8A16-7AC5E1FB4A9FQ33697238-59011C5A-256C-48C0-8EEF-536FD049CAE2Q33943025-0BDF57CE-69A3-471F-88B7-0031A22A6246Q34324102-E2B80F9B-5B62-43E7-962A-A37EF77F5E82Q34362420-78138333-010F-4102-8754-922F206EE11CQ34416308-DB218E44-26C0-4F60-ABBD-237D0ADAFC8EQ34565963-61D68F7A-91B3-47FD-85AC-EF68A284DCD4Q34999542-E74DBD68-702C-43A5-96A5-67BD0E5205D1Q35669897-09D93072-4F07-4486-B3DE-5C0A48174934Q36335857-FA843BEA-825C-4F81-8A76-E689E65A06F5Q36733512-A9B7B728-79CF-45EE-91CB-BA572A88EC86Q36892558-D3B39E1F-608E-468B-BFDA-1E057B7E9AECQ36892562-131279F7-C6F7-4E38-BBD2-CD46B8A4C073Q37082896-4485DCCC-92FD-40BD-BC54-A4BCF37A17C3Q37673351-A251320F-391F-4FDE-8D63-84355015E565Q38148200-E80017A6-6045-49E5-98B7-C6131EEEB2D0Q38206291-D476CC82-A2C7-4031-93C8-C6DCC1C25C7DQ38219588-3D4A4FED-26B9-4E43-A1C4-34236A010CEFQ38254291-BCE13668-584B-485C-9A80-9C32075F78EBQ38361657-BE3F38C8-B856-4812-9A92-1DA6939E23C1Q38423854-CB5F320B-AF16-4968-8CE2-80C8DCA72D9DQ38607875-4709F7A3-6B57-4EC8-ABA7-9419DBDF1612Q38626123-506B8115-5BD7-4F52-B9F9-7F38AB794FF9Q38673817-D70A4226-D944-4E10-ACE0-13491AA87E38Q38836177-93C6DFA4-F3B4-40A0-950E-582DC1AC2231Q38836181-2042E6F7-8FDA-432D-9277-BB7922864CC1Q39027102-95BCC244-27BF-4D21-B031-070A0BBDD986Q40019124-3614A551-3173-4E05-A097-79D8B744CBCBQ42220286-3B70E521-53A6-4BB2-9AB5-7A3ED6D6DE78Q43109013-FF9BDB28-B75C-4FE4-A5A1-1C80372470D4Q44240555-4CBFD83E-4459-4072-8018-D718B4E1E3D5Q45874313-2049EBA8-A5BD-4CAF-8AD7-CB4A63CE8BD6Q47742744-230C1C93-FF10-47A5-BE3E-A62BCC431B73Q47771973-40CB92DB-D3A2-42E1-B06B-C817381F2868Q47885433-CAD5BFF6-CB08-4E2E-A140-FFAA13B93CA4Q48373550-CAA65A5F-FEAE-4503-9E97-3D76B42A7682Q49434482-AD4349DD-B3FD-4935-9E7C-6D307E4C1943Q49837145-A4B1FE88-9203-4D6E-9CDB-031FD6C6A213Q51269698-3B1115EA-5E10-446A-8ACD-7128734DC0AE
P2860
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@ast
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@en
type
label
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@ast
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@en
prefLabel
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@ast
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@en
P2860
P1433
P1476
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
@en
P2860
P356
10.1016/S0268-960X(12)70005-X
P478
26 Suppl 1
P577
2012-04-01T00:00:00Z